Quality assurance in preoperative radiotherapy of rectal cancer: Evaluation of a pre-trial dummy-run

Radiotherapy and Oncology

Volumn 56, Issue 3, 2000, Pages 341-347

  Widder, Joachim ^a   Sedlmayer, Felix ^b   Stanek, Christian ^c   Pötter, Richard ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b L fuer Strahlenther/Radio Onkol   (Austria)

^c Department of Radiooncology ^*  (Austria)

Author keywords

Dummy run; Multi centre trial; Preoperative radiotherapy; Quality assurance; Rectal cancer

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; EVALUATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; QUALITY CONTROL; RECTUM CANCER; TUMOR VOLUME;

ADENOCARCINOMA; AUSTRIA; CLINICAL TRIALS; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; HUMANS; MULTICENTER STUDIES; QUALITY ASSURANCE, HEALTH CARE; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RECTAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0034284347     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(00)00232-2     Document Type: Article

References (16)

1. Aleman B.M.P., Bartelink H., Gunderson L.L. The current role of radiotherapy in colorectal cancer. Eur. J. Cancer. 31A:1995;1333-1339.
2. Bagatzounis A., Kölbl O., Müller G., Oppitz U., Willner J., Flentje M. Das lokoregionäre Rezidiv des Rektumkarzinoms, Eine computertomographische Analyse und em Zielvolumenkonzept für die adjuvante Radiotherapie. Strahlenther. Oncol. 173:1997;68-75.
3. Dusserre A., Garavaglia G., Giraud J.-Y., Bolla M. Quality assurance of the EORTC radiotherapy trial 22863 for prostatic cancer: the dummy run. Radiother. Oncol. 36:1995;229-234.
4. Gunderson L.L., Russell A.H., Llewellyn H.J., Doppke K.P., Tepper J.E. Treatment planning for colorectal cancer: radiation and surgical techniques and value of small-bowel films. Int. J. Radiat. Oncol. Biol. Phys. 11:1985;1379-1793.
5. Holm T., Singnomklao T., Rutqvist L.E., Cedermark B. Adjuvant preoperative radiotherapy in patients with rectal carcinoma. Adverse effects during long-term follow-up of two randomized trials, Cancer. 78:1996;968-976.
6. Horiot J.C., Bosset J.F., Maingon P. Improvement of the curative management of rectal cancers by better use of radiotherapy. Eur. J. Cancer. 31A:1995;1382-1384.
7. Kline R.W., Smith A.R., Coia L.R., et al. Treatment planning for adenocarcinoma of the rectum and sigmoid: a patterns of care study. Int. J. Radiat. Oncol. Biol. Phys. 37:1997;305-311.
8. Krook J.E., Moertel C.G., Gunderson L.L., et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N. Engl. J. Med. 324:1991;709-715.
9. Letschert J.G.J., Lebesque J.V., Aleman B.M.P., et al. The volume effect in radiation-related late small bowel complications: results of a clinical study of the EORTC radiotherapy cooperative group in patients treated for rectal carcinoma. Radiother. Oncol. 32:1994;116-123.
10. Letschert J.G.J., Lebesque J.V., de Boer R.W., Hart A.A.M., Bartelink H. Dose-volume correlation in radiation-related small-bowel complications: a clinical study. Radiother. Oncol. 18:1990;307-320.
11. Martenson J.A., Urias R., Smalley S.R., et al. Radiation therapy quality control in a clinical trial of adjuvant postoperative treatment for rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 32:1994;51-55.
12. O'Connell M.J., Martenson J.A., Wieand H.S., et al. Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy after curative surgery. N. Engl. J. Med. 331:1994;502-507.
13. Tepper J.E. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114. J. Clin. Oncol. 15:1997;2030-2039.
14. Thwaites D., Scalliet P., Leer J.W., Overgaard J. Quality assurance in radiotherapy. Radiother. Oncol. 35:1995;61-73.
15. Valentini V., Genovesi D., Polico C., Capirci C. Quality assurance procedures in radiotherapy of rectal neoplasms. Rays. 21:1996;649-662.
16. van Tienhoven G., van Bree N.A.M., Mijnheer B.J., Bartelink H. Quality assurance of the EORTC trial 22881/10882: assessment of the role of the booster dose in breast conserving therapy: the dummy run. Radiother. Oncol. 22:1991;290-298.